Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 123744 |
Drug Identification Number | 02423766 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 x 1ML VIALS |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-09-25 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-10-07 |
Shortage status | Resolved |
Updated date | 2020-10-08 |
Company comments | Item has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-03 | English | Compare |
v2 | 2020-09-03 | English | Compare |
v3 | 2020-09-03 | French | Compare |
v4 | 2020-09-26 | English | Compare |
v5 | 2020-10-07 | English | Compare |
v6 | 2020-10-07 | French | Compare |
v7 | 2020-10-08 | English | Compare |
Showing 1 to 7 of 7